AI assistant
My Size, Inc. — Director's Dealing 2020
Jun 9, 2020
35445_dirs_2020-06-08_7e9a25e6-a652-46c3-8e6e-09e84d6359a8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: My Size, Inc. (MYSZ)
CIK: 0001211805
Period of Report: 2020-05-25
Reporting Person: Turchinsky Ilia (Chief Technology Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-05-25 | Option to purchase Common Stock (right to buy) | $11.4 | D | 1004 | Disposed | 2024-05-29 | Common Stock, $.001 par value per share (1004) | Direct |
| 2020-05-25 | Option to purchase Common Stock (right to buy) | $1.04 | A | 1004 | Acquired | 2025-05-29 | Common Stock, $.001 par value per share (1004) | Direct |
| 2020-05-25 | Option to purchase Common Stock (right to buy) | $13.65 | D | 2667 | Disposed | 2023-09-06 | Common Stock, $.001 par value per share (2667) | Direct |
| 2020-05-25 | Option to purchase Common Stock (right to buy) | $1.04 | A | 2667 | Acquired | 2024-09-06 | Common Stock, $.001 par value per share (2667) | Direct |
Footnotes
F1: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.
F2: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of May 29, 2025. All of the other terms of the option remained unchanged.
F3: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which one third of the total shares vested on July 1, 2019, one third of the total shares vests on July 1, 2020 and the remaining one third of the total shares vests on July 1, 2021.
F4: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the option granted to the reporting person on April 15, 2019 having a lower exercise price of $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of September 6, 2024. All of the other terms of the option remained unchanged.